Valproic acid in the treatment of epilepsy during the pediatric age

Area of Science:

• Pediatric Neurology
• Epileptology
• Clinical Pharmacology

Background:

• Epilepsy is a common neurological disorder in children.
• Valproic acid is a widely used antiepileptic drug.
• Understanding treatment efficacy and tolerability in pediatric populations is crucial.

Purpose of the Study:

• To evaluate the efficacy and tolerability of valproic acid in pediatric patients with various epilepsy types.
• To assess the clinical and electroencephalogram (EEG) response to valproic acid treatment.
• To determine the safety profile of valproic acid in children with epilepsy.

Main Methods:

• A cohort of 85 pediatric epilepsy patients was treated with valproic acid.
• Clinical and EEG follow-up was conducted for up to 10 months.
• Data on seizure control and adverse events were systematically collected.

Main Results:

• Pediatric epilepsy patients demonstrated high sensitivity to valproic acid.
• Effective seizure control was achieved rapidly across multiple epilepsy syndromes.
• Valproic acid exhibited minimal and tolerable side effects in this cohort.
• Specific epilepsy types showing significant response included myoclonic-astatic epilepsy, juvenile myoclonic epilepsy, classical absence seizures, and photosensitive epilepsy.

Conclusions:

• Valproic acid is a highly effective and well-tolerated treatment for various epilepsy types in children.
• Early and effective seizure control can be achieved with valproic acid in pediatric epilepsy.
• The findings support the continued use of valproic acid as a first-line or adjunctive therapy in pediatric epilepsy management.